JP2024543259A5 - - Google Patents
Info
- Publication number
- JP2024543259A5 JP2024543259A5 JP2024531268A JP2024531268A JP2024543259A5 JP 2024543259 A5 JP2024543259 A5 JP 2024543259A5 JP 2024531268 A JP2024531268 A JP 2024531268A JP 2024531268 A JP2024531268 A JP 2024531268A JP 2024543259 A5 JP2024543259 A5 JP 2024543259A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- naphthamide
- carbamimidoyl
- pyrazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021903789A AU2021903789A0 (en) | 2021-11-24 | Methods of treating sars-cov-2 infection | |
| AU2021903789 | 2021-11-24 | ||
| PCT/AU2022/051405 WO2023092180A1 (en) | 2021-11-24 | 2022-11-24 | Methods of treating sars-cov-2 infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543259A JP2024543259A (ja) | 2024-11-20 |
| JP2024543259A5 true JP2024543259A5 (enExample) | 2025-11-25 |
Family
ID=86538440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024531268A Pending JP2024543259A (ja) | 2021-11-24 | 2022-11-24 | ＳＡＲＳ－ＣｏＶ－２感染を治療する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250009713A1 (enExample) |
| EP (1) | EP4436576A4 (enExample) |
| JP (1) | JP2024543259A (enExample) |
| KR (1) | KR20240110039A (enExample) |
| CN (1) | CN118574614A (enExample) |
| AU (1) | AU2022399231A1 (enExample) |
| CA (1) | CA3238183A1 (enExample) |
| WO (1) | WO2023092180A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115260100B (zh) * | 2022-08-08 | 2023-12-12 | 赛诺瑞生物医药技术(无锡)有限公司 | 一种用于制备冠状病毒治疗药物的取代酰基胍类化合物和用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2826770B1 (en) * | 2005-06-24 | 2018-09-12 | Biotron Limited | Acylguanidine compounds with antiviral activity |
| US20100254942A1 (en) * | 2007-08-03 | 2010-10-07 | Biotron Limited | Hepatitis c antiviral compositions and methods |
| SG11201907034PA (en) * | 2017-02-08 | 2019-08-27 | Biotron Ltd | Methods of treating influenza |
| AU2020390851A1 (en) * | 2019-11-26 | 2022-06-09 | Biotron Limited | Methods of treating HIV-1 infection |
| JP2023512656A (ja) * | 2020-01-27 | 2023-03-28 | ギリアード サイエンシーズ， インコーポレイテッド | ＳＡＲＳ ＣｏＶ－２感染を治療するための方法 |
| CA3172483A1 (en) * | 2020-04-06 | 2021-10-14 | Scott Ellis | Inhalation formulations of 1'-cyano substituted carbanucleoside analogs |
-
2022
- 2022-11-24 JP JP2024531268A patent/JP2024543259A/ja active Pending
- 2022-11-24 EP EP22896871.5A patent/EP4436576A4/en active Pending
- 2022-11-24 AU AU2022399231A patent/AU2022399231A1/en active Pending
- 2022-11-24 CN CN202280089709.6A patent/CN118574614A/zh active Pending
- 2022-11-24 CA CA3238183A patent/CA3238183A1/en active Pending
- 2022-11-24 WO PCT/AU2022/051405 patent/WO2023092180A1/en not_active Ceased
- 2022-11-24 KR KR1020247020169A patent/KR20240110039A/ko active Pending
- 2022-11-24 US US18/712,518 patent/US20250009713A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023002662A5 (enExample) | ||
| JP2024075655A5 (ja) | 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用 | |
| JP2024540183A5 (enExample) | ||
| JP2009535352A5 (enExample) | ||
| JP2009514874A5 (enExample) | ||
| JP2022163049A5 (enExample) | ||
| JP2023076465A5 (enExample) | ||
| JP2025020117A5 (enExample) | ||
| JP2023504415A5 (enExample) | ||
| JP2023175694A5 (enExample) | ||
| JP2023520323A5 (enExample) | ||
| JP2023535744A5 (enExample) | ||
| JP2023071670A5 (enExample) | ||
| JP2024534427A5 (enExample) | ||
| JP2008533127A5 (enExample) | ||
| JP2024504225A5 (enExample) | ||
| JP2020523334A5 (enExample) | ||
| JP2016147914A (ja) | 上気道の疾患およびインフルエンザ症候群を治療するための組成物 | |
| JP2023545372A5 (enExample) | ||
| JP2024543259A5 (enExample) | ||
| JP2025508052A5 (enExample) | ||
| JP2024528731A5 (enExample) | ||
| JP2022177119A5 (enExample) | ||
| JP2013518061A5 (enExample) | ||
| JP2023517130A5 (ja) | Ａｚｄ１６５６又はその薬学的に許容される塩を含む、コロナウイルスによって引き起こされた肺炎及び／又は心筋炎の治療用組成物 |